Skip to main content

Advertisement

SpringerLink
Log in

Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function

  • Short Communication
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Abraham MB, Nicholas JA, Smith GJ, Fairchild JM, King BR, Ambler GR et al (2018) Reduction in hypoglycemia with the predictive low-glucose management system: a long-term randomized controlled trial in adolescents with type 1 diabetes. Diabetes Care 41(2):303–310

    PubMed  Google Scholar 

  2. Levitt DL, Spanakis EK, Ryan KA, Silver KD (2018) Insulin pump and continuous glucose monitor initiation in hospitalized patients with type 2 diabetes mellitus. Diabetes Technol Ther 20(1):32–38

    Article  CAS  PubMed  Google Scholar 

  3. Zivkovic M, Petrovski G, Bitoska I (2018) Glucose control during kidney transplantation in type 1 diabetes patient on sensor augmented pump: a case report. Acta Diabetol. https://doi.org/10.1007/s00592-018-1147-6

    Article  PubMed  Google Scholar 

  4. Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, Asztalos E, Barrett JFR, Sanchez JJ, de Leiva A, Hod M, Jovanovic L, Keely E, McManus R, Hutton EK, Meek CL, Stewart ZA, Wysocki T, O’Brien R, Ruedy K, Kollman C, Tomlinson G, Murphy HR (2017) CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390(10110):2347–2359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gómez AM, Marín Carrillo LF, Arévalo Correa CM, Muñoz Velandia OM, Rondón Sepúlveda MA, Silva Herrera JL, Henao Carrillo DC (2017) Maternal-fetal outcomes in 34 pregnant women with type 1 diabetes in sensor-augmented insulin pump therapy. Diabetes Technol Ther 19(7):417–422

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Badajoz University Hospital, Badajoz, Spain

    Pilar I. Beato-Víbora

  2. Department of Paediatrics, Badajoz University Hospital, Badajoz, Spain

    Francisco J. Arroyo-Díez

Authors
  1. Pilar I. Beato-Víbora
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco J. Arroyo-Díez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pilar I. Beato-Víbora.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the Helsinki Declaration.

Informed consent

Informed consent was obtained from the patient.

Additional information

Managed by Antonio Secchi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beato-Víbora, P.I., Arroyo-Díez, F.J. Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function. Acta Diabetol 55, 1083–1085 (2018). https://doi.org/10.1007/s00592-018-1191-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1191-2

Keywords

Search

Navigation